Clinical trial
Effect of Crestor on Lipoprotein Metabolism in Humans
NCT00214617 · Foundation for Atlanta Veterans Education and Research, Inc., Other · Completed
Key facts
| NCT number | NCT00214617 |
|---|---|
| Title | Effect of Crestor on Lipoprotein Metabolism in Humans |
| Official title | Effect of Crestor on the Kinetics of Plasma Apolipoproteins: Dose-Response Study |
| Lead sponsor | Foundation for Atlanta Veterans Education and Research, Inc., Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | Rosuvastatin at 5 mg/day and 40 mg/day |
| Enrollment | 8 |
| Start date | Jan 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 20, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: